Dose conversion from epoetin alfa to darbepoetin alfa for patients with chronic kidney disease receiving hemodialysis.
Barnett
Arnold L
AL
Sloan School of Management, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Crémieux
Pierre Y
PY
D000068256:Darbepoetin alfa; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006397:Hematinics / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D011994:Recombinant Proteins; D006435:Renal Dialysis; D013810:Therapeutic Equivalency
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa